APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostasis and Tissue Sealing Agents

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.

Selected research

Market Structure

Global Hemostasis and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025190 pages

Choose your research edition.

Industry ResearchHemostasis and Tissue Sealing Agents Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostasis and Tissue Sealing Agents Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Hemostasis and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostasis and Tissue Sealing Agents Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostasis and Tissue Sealing Agents Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.

The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.

Read the full market overview

Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.

North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.

This report provides an overview of the global Hemostasis and Tissue Sealing Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostasis and Tissue Sealing Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostasis and Tissue Sealing Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostasis and Tissue Sealing Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostasis and Tissue Sealing Agents Segment by Company

Johnson & Johnson

Baxter

C R Bard

B Braun

Gelita

Integra Life Sciences

Advance Medical Solution

Pfizer

CSL Behring

CryoLife

Zimmer Biomet

Ferrosan Medical Devices

Medtronic

Smith & Nephew

Z-Medica

Cohera Medical

Marine Polymer

Equimedical

Hemostasis and Tissue Sealing Agents Segment by Type

Hemostasis Agents

Tissue Sealing Agents

Hemostasis and Tissue Sealing Agents Segment by Application

Minimally Invasive Surgery

General Surgery

Others

Hemostasis and Tissue Sealing Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostasis and Tissue Sealing Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostasis and Tissue Sealing Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostasis and Tissue Sealing Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostasis and Tissue Sealing Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostasis and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostasis and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostasis and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostasis and Tissue Sealing Agents Industry Trends Table 2. Hemostasis and Tissue Sealing Agents Industry Drivers Table 3. Hemostasis and Tissue Sealing Agents Industry Opportunities and Challenges Table 4. Hemostasis and Tissue Sealing Agents Industry Restraints Table 5. Global Hemostasis and Tissue Sealing Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostasis and Tissue Sealing Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Manufacturers Table 9. Global Hemostasis and Tissue Sealing Agents Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Hemostasis and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostasis and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostasis and Tissue Sealing Agents Manufacturers, Product Type & Application Table 13. Global Hemostasis and Tissue Sealing Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostasis and Tissue Sealing Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hemostasis Agents Table 17. Major Manufacturers of Tissue Sealing Agents Table 18. Global Hemostasis and Tissue Sealing Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hemostasis and Tissue Sealing Agents Sales by Type (2021-2026) & (K Units) Table 20. Global Hemostasis and Tissue Sealing Agents Sales by Type (2027-2032) & (K Units) Table 21. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Type (2021-2026) Table 22. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Type (2027-2032) Table 23. Global Hemostasis and Tissue Sealing Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hemostasis and Tissue Sealing Agents Revenue by Type (2021-2026) & (K Units) Table 25. Global Hemostasis and Tissue Sealing Agents Revenue by Type (2027-2032) & (K Units) Table 26. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Type (2021-2026) Table 27. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Minimally Invasive Surgery Table 29. Major Manufacturers of General Surgery Table 30. Major Manufacturers of Others Table 31. Global Hemostasis and Tissue Sealing Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hemostasis and Tissue Sealing Agents Sales by Application (2021-2026) & (K Units) Table 33. Global Hemostasis and Tissue Sealing Agents Sales by Application (2027-2032) & (K Units) Table 34. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Application (2021-2026) Table 35. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Application (2027-2032) Table 36. Global Hemostasis and Tissue Sealing Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hemostasis and Tissue Sealing Agents Revenue by Application (2021-2026) & (K Units) Table 38. Global Hemostasis and Tissue Sealing Agents Revenue by Application (2027-2032) & (K Units) Table 39. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Application (2021-2026) Table 40. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Application (2027-2032) Table 41. Global Hemostasis and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hemostasis and Tissue Sealing Agents Sales by Region (2021-2026) & (K Units) Table 43. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Region (2021-2026) Table 44. Global Hemostasis and Tissue Sealing Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Hemostasis and Tissue Sealing Agents Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Hemostasis and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 48. North America Hemostasis and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 49. Europe Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Hemostasis and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 51. Europe Hemostasis and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Hemostasis and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Hemostasis and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 58. Global Hemostasis and Tissue Sealing Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hemostasis and Tissue Sealing Agents Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hemostasis and Tissue Sealing Agents Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Region (2021-2026) Table 62. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Region (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Hemostasis and Tissue Sealing Agents Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Baxter Hemostasis and Tissue Sealing Agents Product Portfolio Table 72. Baxter Recent Development Table 73. C R Bard Company Information Table 74. C R Bard Business Overview Table 75. C R Bard Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. C R Bard Hemostasis and Tissue Sealing Agents Product Portfolio Table 77. C R Bard Recent Development Table 78. B Braun Company Information Table 79. B Braun Business Overview Table 80. B Braun Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. B Braun Hemostasis and Tissue Sealing Agents Product Portfolio Table 82. B Braun Recent Development Table 83. Gelita Company Information Table 84. Gelita Business Overview Table 85. Gelita Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Gelita Hemostasis and Tissue Sealing Agents Product Portfolio Table 87. Gelita Recent Development Table 88. Integra Life Sciences Company Information Table 89. Integra Life Sciences Business Overview Table 90. Integra Life Sciences Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Integra Life Sciences Hemostasis and Tissue Sealing Agents Product Portfolio Table 92. Integra Life Sciences Recent Development Table 93. Advance Medical Solution Company Information Table 94. Advance Medical Solution Business Overview Table 95. Advance Medical Solution Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Advance Medical Solution Hemostasis and Tissue Sealing Agents Product Portfolio Table 97. Advance Medical Solution Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer Hemostasis and Tissue Sealing Agents Product Portfolio Table 102. Pfizer Recent Development Table 103. CSL Behring Company Information Table 104. CSL Behring Business Overview Table 105. CSL Behring Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. CSL Behring Hemostasis and Tissue Sealing Agents Product Portfolio Table 107. CSL Behring Recent Development Table 108. CryoLife Company Information Table 109. CryoLife Business Overview Table 110. CryoLife Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CryoLife Hemostasis and Tissue Sealing Agents Product Portfolio Table 112. CryoLife Recent Development Table 113. Zimmer Biomet Company Information Table 114. Zimmer Biomet Business Overview Table 115. Zimmer Biomet Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Zimmer Biomet Hemostasis and Tissue Sealing Agents Product Portfolio Table 117. Zimmer Biomet Recent Development Table 118. Ferrosan Medical Devices Company Information Table 119. Ferrosan Medical Devices Business Overview Table 120. Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Product Portfolio Table 122. Ferrosan Medical Devices Recent Development Table 123. Medtronic Company Information Table 124. Medtronic Business Overview Table 125. Medtronic Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Medtronic Hemostasis and Tissue Sealing Agents Product Portfolio Table 127. Medtronic Recent Development Table 128. Smith & Nephew Company Information Table 129. Smith & Nephew Business Overview Table 130. Smith & Nephew Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Smith & Nephew Hemostasis and Tissue Sealing Agents Product Portfolio Table 132. Smith & Nephew Recent Development Table 133. Z-Medica Company Information Table 134. Z-Medica Business Overview Table 135. Z-Medica Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Z-Medica Hemostasis and Tissue Sealing Agents Product Portfolio Table 137. Z-Medica Recent Development Table 138. Cohera Medical Company Information Table 139. Cohera Medical Business Overview Table 140. Cohera Medical Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Cohera Medical Hemostasis and Tissue Sealing Agents Product Portfolio Table 142. Cohera Medical Recent Development Table 143. Marine Polymer Company Information Table 144. Marine Polymer Business Overview Table 145. Marine Polymer Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Marine Polymer Hemostasis and Tissue Sealing Agents Product Portfolio Table 147. Marine Polymer Recent Development Table 148. Equimedical Company Information Table 149. Equimedical Business Overview Table 150. Equimedical Hemostasis and Tissue Sealing Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Equimedical Hemostasis and Tissue Sealing Agents Product Portfolio Table 152. Equimedical Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Hemostasis and Tissue Sealing Agents Distributors List Table 156. Hemostasis and Tissue Sealing Agents Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Hemostasis and Tissue Sealing Agents Product Image Figure 2. Global Hemostasis and Tissue Sealing Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostasis and Tissue Sealing Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostasis and Tissue Sealing Agents Sales (2021-2032) & (K Units) Figure 5. Global Hemostasis and Tissue Sealing Agents Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostasis and Tissue Sealing Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hemostasis Agents Image Figure 9. Tissue Sealing Agents Image Figure 10. Global Hemostasis and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hemostasis and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Type (2021-2032) Figure 13. Global Hemostasis and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hemostasis and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Type (2021-2032) Figure 16. Minimally Invasive Surgery Image Figure 17. General Surgery Image Figure 18. Others Image Figure 19. Global Hemostasis and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hemostasis and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hemostasis and Tissue Sealing Agents Sales Market Share by Application (2021-2032) Figure 22. Global Hemostasis and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemostasis and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Application (2021-2032) Figure 25. North America Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Hemostasis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 27. U.S. Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hemostasis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 32. Germany Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hemostasis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 39. China Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 47. Brazil Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Hemostasis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Hemostasis and Tissue Sealing Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hemostasis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 58. North America Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hemostasis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hemostasis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemostasis and Tissue Sealing Agents Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hemostasis and Tissue Sealing Agents Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Hemostasis Agents
  • Tissue Sealing Agents
Applications
  • Minimally Invasive Surgery
  • General Surgery
  • Others
Companies covered
  • Johnson & Johnson
  • Baxter
  • C R Bard
  • B Braun
  • Gelita
  • Integra Life Sciences
  • Advance Medical Solution
  • Pfizer
  • CSL Behring
  • CryoLife
  • Zimmer Biomet
  • Ferrosan Medical Devices
  • Medtronic
  • Smith & Nephew
  • Z-Medica
  • Cohera Medical
  • Marine Polymer
  • Equimedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostasis and Tissue Sealing Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostasis and Tissue Sealing Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostasis and Tissue Sealing Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostasis and Tissue Sealing Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostasis and Tissue Sealing Agents Market Dynamics
  1. 2.1 Hemostasis and Tissue Sealing Agents Industry Trends
  2. 2.2 Hemostasis and Tissue Sealing Agents Industry Drivers
  3. 2.3 Hemostasis and Tissue Sealing Agents Industry Opportunities and Challenges
  4. 2.4 Hemostasis and Tissue Sealing Agents Industry Restraints
3 Hemostasis and Tissue Sealing Agents Market by Manufacturers
  1. 3.1 Global Hemostasis and Tissue Sealing Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostasis and Tissue Sealing Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostasis and Tissue Sealing Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostasis and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostasis and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostasis and Tissue Sealing Agents Manufacturers, Product Type & Application
  7. 3.7 Global Hemostasis and Tissue Sealing Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostasis and Tissue Sealing Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostasis and Tissue Sealing Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostasis and Tissue Sealing Agents Tier 1, Tier 2, and Tier 3
4 Hemostasis and Tissue Sealing Agents Market by Type
  1. 4.1 Hemostasis and Tissue Sealing Agents Type Introduction
  2. 4.1.1 Hemostasis Agents
  3. 4.1.2 Tissue Sealing Agents
  4. 4.2 Global Hemostasis and Tissue Sealing Agents Sales by Type
  5. 4.2.1 Global Hemostasis and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemostasis and Tissue Sealing Agents Sales by Type (2021-2032)
  7. 4.2.3 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemostasis and Tissue Sealing Agents Revenue by Type
  9. 4.3.1 Global Hemostasis and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemostasis and Tissue Sealing Agents Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Type (2021-2032)
5 Hemostasis and Tissue Sealing Agents Market by Application
  1. 5.1 Hemostasis and Tissue Sealing Agents Application Introduction
  2. 5.1.1 Minimally Invasive Surgery
  3. 5.1.2 General Surgery
  4. 5.1.3 Others
  5. 5.2 Global Hemostasis and Tissue Sealing Agents Sales by Application
  6. 5.2.1 Global Hemostasis and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemostasis and Tissue Sealing Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hemostasis and Tissue Sealing Agents Revenue by Application
  10. 5.3.1 Global Hemostasis and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hemostasis and Tissue Sealing Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Application (2021-2032)
6 Global Hemostasis and Tissue Sealing Agents Sales by Region
  1. 6.1 Global Hemostasis and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostasis and Tissue Sealing Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostasis and Tissue Sealing Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostasis and Tissue Sealing Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostasis and Tissue Sealing Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostasis and Tissue Sealing Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostasis and Tissue Sealing Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostasis and Tissue Sealing Agents Revenue by Region
  1. 7.1 Global Hemostasis and Tissue Sealing Agents Revenue by Region
  2. 7.1.1 Global Hemostasis and Tissue Sealing Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostasis and Tissue Sealing Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostasis and Tissue Sealing Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostasis and Tissue Sealing Agents Revenue (2021-2032)
  8. 7.2.2 North America Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostasis and Tissue Sealing Agents Revenue (2021-2032)
  11. 7.3.2 Europe Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostasis and Tissue Sealing Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Hemostasis and Tissue Sealing Agents Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Hemostasis and Tissue Sealing Agents Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 C R Bard
  14. 8.3.1 C R Bard Company Information
  15. 8.3.2 C R Bard Business Overview
  16. 8.3.3 C R Bard Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 C R Bard Hemostasis and Tissue Sealing Agents Product Portfolio
  18. 8.3.5 C R Bard Recent Developments
  19. 8.4 B Braun
  20. 8.4.1 B Braun Company Information
  21. 8.4.2 B Braun Business Overview
  22. 8.4.3 B Braun Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 B Braun Hemostasis and Tissue Sealing Agents Product Portfolio
  24. 8.4.5 B Braun Recent Developments
  25. 8.5 Gelita
  26. 8.5.1 Gelita Company Information
  27. 8.5.2 Gelita Business Overview
  28. 8.5.3 Gelita Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gelita Hemostasis and Tissue Sealing Agents Product Portfolio
  30. 8.5.5 Gelita Recent Developments
  31. 8.6 Integra Life Sciences
  32. 8.6.1 Integra Life Sciences Company Information
  33. 8.6.2 Integra Life Sciences Business Overview
  34. 8.6.3 Integra Life Sciences Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Integra Life Sciences Hemostasis and Tissue Sealing Agents Product Portfolio
  36. 8.6.5 Integra Life Sciences Recent Developments
  37. 8.7 Advance Medical Solution
  38. 8.7.1 Advance Medical Solution Company Information
  39. 8.7.2 Advance Medical Solution Business Overview
  40. 8.7.3 Advance Medical Solution Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Advance Medical Solution Hemostasis and Tissue Sealing Agents Product Portfolio
  42. 8.7.5 Advance Medical Solution Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Hemostasis and Tissue Sealing Agents Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 CSL Behring
  50. 8.9.1 CSL Behring Company Information
  51. 8.9.2 CSL Behring Business Overview
  52. 8.9.3 CSL Behring Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CSL Behring Hemostasis and Tissue Sealing Agents Product Portfolio
  54. 8.9.5 CSL Behring Recent Developments
  55. 8.10 CryoLife
  56. 8.10.1 CryoLife Company Information
  57. 8.10.2 CryoLife Business Overview
  58. 8.10.3 CryoLife Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CryoLife Hemostasis and Tissue Sealing Agents Product Portfolio
  60. 8.10.5 CryoLife Recent Developments
  61. 8.11 Zimmer Biomet
  62. 8.11.1 Zimmer Biomet Company Information
  63. 8.11.2 Zimmer Biomet Business Overview
  64. 8.11.3 Zimmer Biomet Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zimmer Biomet Hemostasis and Tissue Sealing Agents Product Portfolio
  66. 8.11.5 Zimmer Biomet Recent Developments
  67. 8.12 Ferrosan Medical Devices
  68. 8.12.1 Ferrosan Medical Devices Company Information
  69. 8.12.2 Ferrosan Medical Devices Business Overview
  70. 8.12.3 Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Product Portfolio
  72. 8.12.5 Ferrosan Medical Devices Recent Developments
  73. 8.13 Medtronic
  74. 8.13.1 Medtronic Company Information
  75. 8.13.2 Medtronic Business Overview
  76. 8.13.3 Medtronic Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medtronic Hemostasis and Tissue Sealing Agents Product Portfolio
  78. 8.13.5 Medtronic Recent Developments
  79. 8.14 Smith & Nephew
  80. 8.14.1 Smith & Nephew Company Information
  81. 8.14.2 Smith & Nephew Business Overview
  82. 8.14.3 Smith & Nephew Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Smith & Nephew Hemostasis and Tissue Sealing Agents Product Portfolio
  84. 8.14.5 Smith & Nephew Recent Developments
  85. 8.15 Z-Medica
  86. 8.15.1 Z-Medica Company Information
  87. 8.15.2 Z-Medica Business Overview
  88. 8.15.3 Z-Medica Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Z-Medica Hemostasis and Tissue Sealing Agents Product Portfolio
  90. 8.15.5 Z-Medica Recent Developments
  91. 8.16 Cohera Medical
  92. 8.16.1 Cohera Medical Company Information
  93. 8.16.2 Cohera Medical Business Overview
  94. 8.16.3 Cohera Medical Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cohera Medical Hemostasis and Tissue Sealing Agents Product Portfolio
  96. 8.16.5 Cohera Medical Recent Developments
  97. 8.17 Marine Polymer
  98. 8.17.1 Marine Polymer Company Information
  99. 8.17.2 Marine Polymer Business Overview
  100. 8.17.3 Marine Polymer Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Marine Polymer Hemostasis and Tissue Sealing Agents Product Portfolio
  102. 8.17.5 Marine Polymer Recent Developments
  103. 8.18 Equimedical
  104. 8.18.1 Equimedical Company Information
  105. 8.18.2 Equimedical Business Overview
  106. 8.18.3 Equimedical Hemostasis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Equimedical Hemostasis and Tissue Sealing Agents Product Portfolio
  108. 8.18.5 Equimedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostasis and Tissue Sealing Agents Value Chain Analysis
  2. 9.1.1 Hemostasis and Tissue Sealing Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostasis and Tissue Sealing Agents Production Mode & Process
  6. 9.2 Hemostasis and Tissue Sealing Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostasis and Tissue Sealing Agents Distributors
  9. 9.2.3 Hemostasis and Tissue Sealing Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst